We identified two peptides derived from the amphipathic helix of NINJ1 and NINJ2, called NINJ1-B and NINJ2-B, respectively, were able to disrupt the interaction between NINJ1 and NINJ2 and inhibit cancer cell growth in NINJ1/2- and p53-dependent manners. The gene discussed is TP53; the disease is cancer.